Hikma Pharma Appoints Riad Mishlawi As CEO, Effective Sept. 1

(RTTNews) - Hikma Pharmaceuticals PLC (HIK, HIK.L) announced Wednesday that it has appointed Riad Mishlawi, President of the Group's Injectables business, as Chief Executive Officer, effective September 1. He will also join Hikma's Board of Directors on the same date. https://www.nasdaq.com/articles/hikma-pharma-appoints-riad-mishlawi-as-ceo-effective-sept.-1